• 'kunalremedies@gmail.com

KRPL | KUNAL REMEDIES PVT. LTD.

Production Technology

D10 500ML

Dextrose Injection IP (Multiple Strength 10%,25% & 50% w/v)
  • Composition: Each 100ml contains
      • Dextrose Anhydrous IP - 10gm
      • Water for injection IP - q.s.
  • Packing: 500ml, 1000ml (PP & FFS)
  • Indication:
      • Dextrose Anhydrous IP - 10gm



  • OFLOXACIN 100ML

    Ofloxacin Injection IP
  • Composition: Each 100ml contains
      • Ofloxacin IP - 0.2 gm
      • Sodium Chloride IP - 0.9 gm
      • Water for injection IP - q.s.
  • Packing: 100ml (PP, FFS & Glass)
  • Indication:
      • Susceptible infections including acute bacterial exacerbation of chronic bronchitis,
      • Community-acquired pneumonia,
      • Acute pelvic inflammatory disease (PID),
      • Acute, uncomplicated cervical and urethral gonorrhea, urethritis, cervicitis, uncomplicated cystitis,
      • Uncomplicated skin and skin structure,
      • Complicated UTIs



  • LEVOFLOXACIN 100ML

    Levofloxacin Injection IP
  • Composition:  Each 100ml contains
      • Levofloxacin IP - 0.5 gm
      • Sodium Chloride IP - 0.9 gm
      • Water for injection IP - q.s.
  • Packing: 100ml (PP, FFS & Glass)
  • Indication:
      • Susceptible bacterial infections including acute sinusitis,
      • Acute exacerbations of chronic bronchitis, nosocomial or community-acquired pneumonia (CAP),
      • UTIs, acute pyelonephritis, chronic bacterial prostatitis,
      • Skin and skin structure infections.



  • K-LYTE P 500ML

    Multiple electrolyte & Dextrose Injection Type - I IP
  • Composition: Each 100ml contains
      • Dextrose anhydrous IP - 5 gm
      • Magnesium Chloride IP - 0.031 gm
      • Potassium Chloride IP - 0.13 gm
      • Sodium Acetate IP - 0.320 gm
      • Dibasic Potassium Phosphate USP - 0.026 gm
      • Water for injection IP - q.s.
  • Packing:  100ml, 500ml (PP, FFS & Glass)
  • Indication:
      • Used with great care in patients with congestive heart failure.
      • Severe renal insufficiency.
      • In clinical states in which there exists edema with sodium retention.
      • Used with great care in patients with metabolic or respiratory alkalosis.
      • The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.